Social prescriptions and micro-learning to improve cancer care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project pilots a patient-centered intervention for cancer care that combines social prescriptions with web-based micro-learning modules. It builds on ongoing symptom monitoring to tailor care and aims to improve access to high-quality, equitable support for diverse patient groups, including those in underserved areas. Enrollment includes adult patients with various cancer types and their nominated support persons, across multiple German hospitals, with an emphasis on those who can engage in German-language questionnaires and interviews. The approach relies on interdisciplinary collaboration and low-cost strategies to sustain impact beyond the funding period. Outcomes will be informed by patient-reported measures and caregiver inputs to assess feasibility and potential benefits.

Why it matters

Who can join: the full rules

Inclusion Criteria for patients:

* aged at least 18 years
* primary diagnosis of early-stage or advanced-stage lung cancer, colorectal cancer, hematological neoplasm or malignant melanoma within the past 12 months
* expected survival of at least 18 months
* sufficient German language proficiency to complete questionnaires and interviews
* attendance at the medical oncology units of participating hospitals
* provision of written informed consent
* ECOG Performance Status 0-2
* ability to name an eligible SP.

Inclusion criteria for Support Persons:

* being nominated by the patient as someone who provides support, encouragement or assistance in coping with their cancer
* aged at least 18 years
* proficiency in German
* provision of written informed consent.

Exclusion Criteria:

Inability to

* provide informed consent
* independently complete interviews and/or questionnaires due to impaired speech, vigilance, or comprehension.

Where it's running

• University Hospital Regensburg
  Regensburg, Bavaria, Germany Recruiting
• University Hospital Augsburg
  Augsburg, Bavaria, Germany Not yet recruiting
• University Hospital Erlangen
  Erlangen, Bavaria, Germany Not yet recruiting
• University Regensburg
  Regensburg, Bavaria, Germany Active not recruiting
• University Hospital Würzburg
  Würzburg, Bavaria, Germany Not yet recruiting
• Faculty of Law, Business & Economics, Inst. for Healthcare Management & Health Sciences
  Bayreuth, Germany Active not recruiting

Study contacts

• Study coordinator: Anne Herrmann, Prof. Dr.
• Email: Anne.Herrmann@ur.de
• Phone: +49 941 944 5220

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment

  This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07816263

• Personal health app in young-to-midlife adults in Hong Kong

  This trial tests whether the Wellnuts self-health assessment app helps asymptomatic adults in Hong Kong become more health-aware and proactive about care, compared with standard online health resources.

  Recruiting The University of Hong Kong · Hong Kong · NCT07720245

• Precision navigation to boost cancer screening participation in high-risk communities

  This study tests whether a personalized navigation program helps adults aged 45–74 in Chinese communities who are at high risk for several cancers to complete recommended free cancer screenings.

  Recruiting at 3 sites Hunan Cancer Hospital · Huaihua, Hunan and 2 other locations · NCT07676383

• LRRC15-targeted PET imaging for more precise diagnosis and staging of pancreatic, breast, lung, sarcoma and head-and-neck cancers

  This project tests whether an LRRC15-targeted PET scan can better detect and stage LRRC15-expressing cancers and measures how the tracer behaves in healthy adults.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07552467

• AI language tools to help tumor care teams write MDT reports

  We will test whether AI language tools can help junior cancer doctors write MDT diagnosis and treatment reports more accurately and faster.

  Recruiting at 2 sites Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong and 1 other locations · NCT07504367

• Riluzole to prevent thinking and memory problems during chemotherapy

  This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07447050

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.